Shares of MannKind Corp. (NASDAQ:MNKD) fall as much as 27.105% prior to Tuesday’s Endocrinologic and Metabolic Drugs Advisory Committee Meeting. MannKind Corporation (NASDAQ:MNKD) stock performance was -16.77% in last session and finished the day at $4.02. Traded volume was 30,207,668 million shares in the last session and the average volume of the stock remained 7.92 million shares. The beta of the stock remained 1.47. MannKind … Continue reading Bearish Stocks: MannKind Corporation (NASDAQ:MNKD), Prana Biotechnology Limited (NASDAQ:PRAN), Oi SA (ADR) (NYSE:OIBR), Idera Pharmaceuticals (NASDAQ:IDRA)